Dennis Liang Fei
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$4.2MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $4.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 2, 2026 | NIH | SBIR Phase I Development of novel WNT inhibitors to treat colorectal cancers | $400K | — |
| Jul 19, 2024 | NIH | SBIR Phase II Small Molecule MYC Degraders as Novel Cancer Therapeutic Agents | $1.1M | — |
| Sep 22, 2023 | NIH | SBIR Phase II Small Molecule MYC Degraders as Novel Cancer Therapeutic Agents | $940K | — |
| Aug 31, 2022 | NIH | SBIR Phase II Development of Notch1-selective Small Molecule Inhibitor for the Treatment of Cancer | $1.0M | — |
| Apr 5, 2022 | NIH | SBIR Phase I Small Molecule N-myc Degraders as Novel Cancer Therapeutic Agents | $400K | — |
| Apr 17, 2020 | NIH | SBIR Phase I Small Molecule Inhibitors of Notch Activation Complex Kinase (NACK) as Novel Cancer Therapeutic Agents | $400K | — |
Peer ranks
Federal funding#87
Awards as PI#117
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.